Open access
Oct 2026
AI-enabled drug repurposing in Alzheimer’s disease: from computational nomination to pharmacological proof
Rather than cataloguing methods and candidates, this work appraise leading drugs at the individual-molecule level and proposes explicit criteria for progression from computational nomination to clinical testing, which defines seven requirements for clinical progression.
Xin-Zhong Li, Illana Gozes
· Frontiers in Pharmacology · 0 citations